These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function. Scott JZ, Kletzky OA, Brenner PF, Mishell DR. Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356 [Abstract] [Full Text] [Related]
5. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW, de la Peña A, Chenault CB, Cervantes A. Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928 [Abstract] [Full Text] [Related]
6. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel. Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U. Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174 [Abstract] [Full Text] [Related]
7. Pituitary and ovarian function in women receiving hormonal contraception. Cohen BL, Katz M. Contraception; 1979 Nov 15; 20(5):475-87. PubMed ID: 393456 [Abstract] [Full Text] [Related]
14. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins. McGuire JL, Bariso CD, Yuliano E, Hume RJ, Pasquale SA. Contraception; 1975 Mar 15; 11(3):329-38. PubMed ID: 1116369 [Abstract] [Full Text] [Related]
15. Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users. van der Spuy ZM, Sohnius U, Pienaar CA, Schall R. Contraception; 1990 Dec 15; 42(6):597-609. PubMed ID: 2128047 [Abstract] [Full Text] [Related]
17. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial. Moutos D, Smith S, Zacur H. Contraception; 1995 Aug 15; 52(2):105-9. PubMed ID: 8536446 [Abstract] [Full Text] [Related]
18. Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive. Spellacy WN, Kalra PS, Buhi WC, Birk SA. Am J Obstet Gynecol; 1980 May 01; 137(1):109-15. PubMed ID: 6768295 [Abstract] [Full Text] [Related]
19. Further studies on pituitary and ovarian function in women receiving hormonal contraception. Cohen BL, Katz M. Contraception; 1981 Aug 01; 24(2):159-72. PubMed ID: 6794980 [Abstract] [Full Text] [Related]
20. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel. Gaspard UJ, Romus MA, Gillain D, Duvivier J, Demey-Ponsart E, Franchimont P. Contraception; 1983 Jun 01; 27(6):577-90. PubMed ID: 6225622 [Abstract] [Full Text] [Related] Page: [Next] [New Search]